Files
Download Full Text (1.8 MB)
Contents
- Advances in Gene Mapping Technology May Accelerate Cancer Drug Development: As new technology makes DNA sequencing faster and less expensive, researchers aim to exploit these abilities to develop novel targeted cancer therapies
- Compass: Advanced Renal Cell Carcinoma: Surgery and/or systemic therapy can help manage disease
- HOUSE CALL: Do Nutritional Supplements Help Prevent Cancer ?: For many people, the risks may outweigh the benefits
- INBRIEF: Drug Provides Symptom Reduction and Survival Advantages for Myelofibrosis Patients
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
5-1-2012
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Draetta, Giulio; Protopopov, Alexei; Jonasch, Eric; Tannir, Nizar M.; Matin, Surena F.; Wood, Christopher G.; Verstovsek, Srdan; Sequence Analysis, DNA; Drug Development; Chromosome Mapping; Carcinoma, Renal Cell; Antineoplastic Agents; Cytokines; Immunotherapy; Clinical Trials as Topic; Dietary Supplements; Vitamin D; Primary Myelofibrosis; Janus Kinase 2.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Tutt, Bryan and Hosemann, Sunni, "OncoLog, Volume 57, Number 05, May 2012" (2012). OncoLog MD Anderson's Report to Physicians (All issues). 225.
https://openworks.mdanderson.org/oncolog/225
Conditions Governing Access
Open
